NZ336969A - Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists - Google Patents
Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonistsInfo
- Publication number
- NZ336969A NZ336969A NZ336969A NZ33696998A NZ336969A NZ 336969 A NZ336969 A NZ 336969A NZ 336969 A NZ336969 A NZ 336969A NZ 33696998 A NZ33696998 A NZ 33696998A NZ 336969 A NZ336969 A NZ 336969A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- agonists
- substituted
- alkoxy
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The substituted benzimidazole-alkoxy-amine derivatives or pharmaceutically acceptable salts thereof have the formula I wherein: R1 is hydrogen, trifluoromethyl, pentafluoroethyl, heptafluoropropyl, alkyl or benzyl optionally substituted by one to three substituents selected from halogen, amino, nitro, hydroxy, alkoxy; R2 is hydrogen or alkyl; R3 is hydrogen, alkyl, cyclohexylmethyl, -(CH2)mAr or phenylbutyl or NR2R3 is 1,2,3,4-tetrahydroquinolin-1-yl or 1,2,3,4-tetrahydroisoquinolin-2-yl; Ar is optionally substituted phenyl, thienyl, furanyl, or pyridinyl, Y is halogen, alkyl, amino or alkoxy and n is 1-5. A pharmaceutical composition thereof is useful for treating diseases that respond to treatment with D2 agonists.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80127697A | 1997-02-18 | 1997-02-18 | |
PCT/US1998/000613 WO1998035945A1 (en) | 1997-02-18 | 1998-01-13 | 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ336969A true NZ336969A (en) | 2001-03-30 |
Family
ID=25180658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ336969A NZ336969A (en) | 1997-02-18 | 1998-01-13 | Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0973749A1 (en) |
JP (1) | JP2001509814A (en) |
KR (1) | KR20000071129A (en) |
CN (1) | CN1252793A (en) |
AR (1) | AR011136A1 (en) |
AU (1) | AU746717B2 (en) |
BR (1) | BR9807701A (en) |
CA (1) | CA2278700A1 (en) |
HU (1) | HUP0001302A3 (en) |
IL (1) | IL131158A0 (en) |
NZ (1) | NZ336969A (en) |
TW (1) | TW513415B (en) |
WO (1) | WO1998035945A1 (en) |
ZA (1) | ZA981309B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541502B1 (en) * | 2001-07-20 | 2003-04-01 | Wyeth | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
CN101597262A (en) | 2002-03-05 | 2009-12-09 | 特兰斯泰克制药公司 | The list and the bicyclic pyrrole derivatives that suppress part and advanced glycation end product acceptor interaction |
EP2470510B1 (en) | 2009-09-30 | 2014-05-14 | TransTech Pharma, LLC | Substituted imidazole derivatives for treatment of alzheimers disease. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
PT707007E (en) * | 1994-10-14 | 2002-06-28 | Merck Patent Gmbh | AMINO DERIVATIVES (TIO) ETER AS ACTIVE AGENTS IN THE CNS |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
CA2264080A1 (en) * | 1996-08-27 | 1998-03-05 | Richard Eric Mewshaw | 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands |
-
1998
- 1998-01-13 HU HU0001302A patent/HUP0001302A3/en unknown
- 1998-01-13 KR KR1019997007418A patent/KR20000071129A/en not_active Application Discontinuation
- 1998-01-13 CN CN98804249A patent/CN1252793A/en active Pending
- 1998-01-13 NZ NZ336969A patent/NZ336969A/en unknown
- 1998-01-13 WO PCT/US1998/000613 patent/WO1998035945A1/en not_active Application Discontinuation
- 1998-01-13 EP EP98902513A patent/EP0973749A1/en not_active Withdrawn
- 1998-01-13 BR BR9807701-5A patent/BR9807701A/en not_active IP Right Cessation
- 1998-01-13 IL IL13115898A patent/IL131158A0/en unknown
- 1998-01-13 CA CA002278700A patent/CA2278700A1/en not_active Abandoned
- 1998-01-13 AU AU59153/98A patent/AU746717B2/en not_active Ceased
- 1998-01-13 JP JP53572798A patent/JP2001509814A/en active Pending
- 1998-02-03 TW TW087101275A patent/TW513415B/en active
- 1998-02-11 AR ARP980100617A patent/AR011136A1/en not_active Application Discontinuation
- 1998-02-17 ZA ZA9801309A patent/ZA981309B/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0001302A3 (en) | 2001-07-30 |
CN1252793A (en) | 2000-05-10 |
AU746717B2 (en) | 2002-05-02 |
EP0973749A1 (en) | 2000-01-26 |
JP2001509814A (en) | 2001-07-24 |
KR20000071129A (en) | 2000-11-25 |
IL131158A0 (en) | 2001-01-28 |
CA2278700A1 (en) | 1998-08-20 |
WO1998035945A1 (en) | 1998-08-20 |
ZA981309B (en) | 1999-08-17 |
TW513415B (en) | 2002-12-11 |
HUP0001302A2 (en) | 2001-05-28 |
AR011136A1 (en) | 2000-08-02 |
BR9807701A (en) | 2000-05-02 |
AU5915398A (en) | 1998-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1566379A4 (en) | QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME | |
ES2196396T3 (en) | HETEROAROMATIC COMPOUNDS OF 5 MEMBERS CONTAINING OXYGEN OR SULFUR AS INHIBITORS OF THE XA FACTOR. | |
FI970148A (en) | Use of heterocyclic compounds as dopamine D3 ligands | |
MXPA05012415A (en) | Isoquinoline derivatives and their use as gfat inhibitors. | |
NO304946B1 (en) | Xanthine derivative and its use | |
ES2174757A1 (en) | Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases | |
JO2311B1 (en) | Alkyne-aryl phosphodiesterase-4 inhibitors | |
NZ510097A (en) | Pyrroloindoles, pyridoindoles and azepinoindoles useful as 5-HT2C agonists | |
SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
ES8404990A1 (en) | Anti-hypertensive prolinol-based peptides. | |
MXPA05007115A (en) | Novel cb 1 receptor inverse agonists. | |
TW200503712A (en) | (2-carboxamido)(3-amino)thiophene compounds | |
EP1140900A4 (en) | Pyrazole compounds and uses thereof | |
BR0015195A (en) | Compound, pharmaceutical composition, use of a compound, and, methods for treating a condition associated with reduced nicotine transmission for the treatment or prophylaxis of psychotic disorders or disorders of intellectual impairment and for the treatment or prophylaxis of human diseases or conditions | |
GEP20053626B (en) | Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof | |
DE69724098D1 (en) | CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININE AGONISTS | |
MX9806171A (en) | 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors. | |
AU1367497A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma | |
ES2180449A1 (en) | Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence | |
HUP0101469A2 (en) | 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as alpha-adrenoceptor agonists with improved metabolic stability | |
NZ336969A (en) | Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists | |
ATE330958T1 (en) | PYRAZINO 1'2':1,6ÖPYRIDO 3,4-BÖINDOL DERIVATIVES | |
GB0003257D0 (en) | Heterocyclic compounds and their therapeutic use | |
MXPA03000887A (en) | Fused heterocyclic derivatives as phosphodiesterase inhibitors. | |
NZ337271A (en) | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives and their use as dopamine autoreceptor (D2) agonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |